Model of new tuberculosis vaccine shows its potential impact and value in South Africa and India
Two years of battling COVID-19 has been bad news for tuberculosis (TB) programmes. Respiratory clinicians and researchers have had their time and focus directed elsewhere. And TB has taken advantage. In 2021, the number of TB deaths rose for the first time in over a decade. The barriers caused by lockdowns and overstretched healthcare systems […]